RecruitingPhase 2NCT04565925
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Sponsor
The University of Texas Medical Branch, Galveston
Enrollment
24 participants
Start Date
Jul 7, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Placebo and a drug called Sildenafil Citrate for people with spinal cord injuries and urinary incontinence. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 70 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSildenafil Citrate
Sildenafil 20mg TID for 4 weeks
DRUGPlacebo
Placebo (Lactose) TID for 4 weeks
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04565925
Related Trials
Deciphering Preserved Autonomic Function After Spinal Cord Injury
NCT044933721 location
Implementing a Mobile Health Application for Women Veterans With Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0
NCT072194331 location
The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation
NCT074308652 locations
NXT Post-Market Clinical Follow-up
NCT063363045 locations
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
NCT064432811 location